Beruflich Dokumente
Kultur Dokumente
patient imprint
PHYSICIAN'S ORDER SHEET
Stroke – ischemic
Another brand of a generically equivalent product identical in dosage
form and content of active ingredient may be administered unless
indicated.
Allergies:_______________
Admission Status g Blood gas, arterial now if not done and ________.
c
d
e
f
g Admit to inpatient to Dr. ______service.
c
d
e
f c Blood gas, venous now if not done and ________.
d
e
f
g
c Admit to observation to Dr. _________ service.
d
e
f
g Source
Admit Location c Pulmonary Function Testing
d
e
f
g
c Admit to location __________________
d
e
f
g c FVC/negative inspiratory force every 6 hours
d
e
f
g
Code Status c Ventilator settings
d
e
f
g
Diet
g Resuscitation status Full Code
c
d
e
f
c Resuscitation status Do Not Resuscitate / Do Not
d
e
f
g g NPO / NPO except po meds with sips.
c
d
e
f
Intubate (allow natural death) c Clear liquids
d
e
f
g
c Resuscitation status Partial Code
d
e
f
g c Regular diet
d
e
f
g
Vital Signs c Therapeutic diet ____________.
d
e
f
g
g Vitals per unit protocol
c
d
e
f
IV Fluids
c Vital signs every______hours and then
d
e
f
g c Sodium Chloride 0.9% @ ______mL/hr for 24 hours.
d
e
f
g
_____________ c Additives ______________________
d
e
f
g
Pulse oximetry c Saline lock.
d
e
f
g
c Continuous
d
e
f
g Medications
c Spot q shift and prn
d
e
f
g Reminders
Activity Avoid sublingual NIFEdipine Evidence
Avoid the routine use of a therapeutic dose of low
g Ambulate with assistance.
c
d
e
f
molecularweight heparin Evidence
c Bed rest / bed rest with bedside commode
d
e
f
g
Avoid the routine use of a therapeutic dose of
c Up ad lib
d
e
f
g unfractionated heparin Evidence
Nursing Orders Evidence to support the routine use of colony
Assessments stimulating factors is inconclusive Evidence
b Stand Dysphagia Protocol/Bedside swallowing
c
d
e
f
g Platelet Inhibitors
evaluation Evidence Combination Agents Evidence
c Glucose, blood, fingerstick. _______ One Time. Other
d
e
f
g Consider aspirindipyridamole within 48 hours of
Frequency _______________ If blood glucose greater admission and upon discharge in patients who do not
than or equal to ____, intiate glycemic control have an indication for warfarin
protocol. c aspirindipyridamole/AGGRENOX 1 capsule,
d
e
f
g
g Measure and document intake and output Total for
c
d
e
f sustained release orally 2 times a day
every 8 hours Salicylates Evidence
c Measure weight
d
e
f
g Aspirin should be administered within 4 hours of
Contingency admission and prescribed upon discharge to patients
c Notify provider specify parameters temp > 101; HR <
d
e
f
g who do not have an indication for warfarin
60 or > 120, RR < 8 or > 30, SBP < 90 or > 180; UO c aspirin 81 milligram orally once a day
d
e
f
g
< 120 in 4 hours, or deterioration in neurologic Thienopyridines Evidence
status. A thienopyridine should be administered within 6
Interventions hours of admission and prescribed upon discharge to
c Elevate head of bed to ___ degrees.
d
e
f
g patients who do not have an indication for warfarin
c Urinary catheter initiation/management
d
e
f
g and who have a contraindication to aspirin, or have
c Urinary straight catheterization
d
e
f
g severe peripheral vascular disease or have
c Nasogastric/orogastric tube insertion/management
d
e
f
g underlying cardiac indication.
Respiratory c clopidogrel /PLAVIX 75 milligram orally once a day
d
e
f
g
c Oxygen via __________@ _____ to maintain O2 sat at
d
e
f
g
90% or greater.
c Biphasic positive airway pressure (BIPAP)
d
e
f
g
c Continuous positive airway pressure (CPAP)
d
e
f
g
Order Initiated By: _________________________ Date/Time: _______________
Physician Signature: ________________________ Date/Time: _______________
Released: April 2, 2009
Telephone/Verbal Orders: gc Read Back g
d
e
f c Confirmed
d
e
f Page &p of &P
patient imprint
PHYSICIAN'S ORDER SHEET
Another brand of a generically equivalent product identical in dosage
form and content of active ingredient may be administered unless
indicated.
In the absence of cardiac indications, it is Severe Pain (710) Evidence
recommended that aspirin and clopidogrel not be Consider the use of an opioid analgesic; morphine at
used in combination for stroke prevention, given the a dose of 0.1 mg/kg body weight has limited
apparent lack of greater efficacy compared with effectiveness Evidence
clopidogrel or aspirin alone and the substantially c HYDROmorphone /DILAUDID 1 milligram SC/IV
d
e
f
g
increased risk of bleeding complications every __ 4 hrs. __ 6 hours as needed for pain
LipidRegulating Agents Evidence c morphine ____ milligram intravenously every
d
e
f
g
Reminders ____hours as needed for pain
Patients with cerebrovascular disease in the presence c morphine ____mg intravenously every 5 minutes to
d
e
f
g
of coronary heart disease or symptomatic a maximum of 10 mg/hr.
atherosclerotic disease should be treated with a 3 Antidotes and Rescue Agents
hydroxy3methylglutaryl coenzyme A reductase c naloxone /NARCAN ___ (0.42) milligram
d
e
f
g
inhibitor to reduce lowdensity lipoprotein cholesterol intravenously every ____min. (23) as needed for
levels to less than 100 mg/dL (less than 70 mg/dL for opiate reversal to improve mentation and RR > 10
veryhighrisk patients); secondary goals of therapy and notify physician STAT
include normalizing triglycerides and reducing non– Antipyretics
highdensity lipoprotein cholesterol levels to less than c acetaminophen /TYLENOL 650 milligram orally or
d
e
f
g
130 mg/dL Evidence rectally every 4 hours as needed for fever >100.4
HMGCoA Reductase Inhibitors c acetaminophen /TYLENOL 650 milligram orally or
d
e
f
g
c atorvastatin /LIPITOR 10 milligram orally once a
d
e
f
g rectally every 6 hours as needed for fever greater
day in the evening than 100.4
c
d
e
f
g atorvastatin /LIPITOR 20 milligram orally once a Laxatives
day in the evening c magnesium hydroxide /MILK OF MAGNESIA 30
d
e
f
g
c
d
e
f
g atorvastatin /LIPITOR 40 milligram orally once a milliliter orally once a day as needed for constipation
day in the evening c docusate sodium /COLACE 100 milligram orally 2
d
e
f
g
c simvastatin /ZOCOR 20 milligram orally once a day,
d
e
f
g times a day
in the evening c bisacodyl /DULCOLAX 5 milligram orally once a day as
d
e
f
g
c simvastatin /ZOCOR 40 milligram orally once a day,
d
e
f
g needed for constipation
in the evening c bisacodyl /DULCOLAX 10 milligram suppository
d
e
f
g
Anticoagulants rectally once a day as needed for constipation
c warfarin/COUMADIN ____mg orally daily.
d
e
f
g DVT Prophylaxis
Analgesics Mechanical methods of prophylaxis should be used
Mild Pain (13) Evidence primarily in patients who are at high risk of bleeding or
as an adjunct to anticoagulantbased prophylaxis.
c
d
e
f
g acetaminophen /TYLENOL ____650 mg ____650 mg
orally or rectally _____every 4 hours ____every 6 Consider renal impairment when deciding on doses of
hours as needed for pain LMWH, the direct thrombin inhibitors, and other
antithrombotic drugs that are cleared by the kidneys,
c ibuprofen /MOTRIN 400 milligram orally every 4
d
e
f
g
particularly in elderly patients and those who are at high
hours as needed for pain
risk for bleeding.
(Contraindicated in pregnant women and children < 6
In acutely ill medical patients who have been admitted
mos. of age)
to the hospital with CHF or severe respiratory disease,
Moderate Pain (46)
or who are confined to bed and have one or more
c hydrocodone/APAP/LORTAB
d
e
f
g adtioanla risk factors, inclujding active CA, previous
____5/500_____7.5/500 ______10/500 tablet orally
VTE, sepsis, acute neurologic disease, or inflammatory
every ____4 hr._____6 hr. as needed for pain
bowel disease, prophylaxis with LDUH or LMWH is
c oxycodoneAPAP/PERCOCET
d
e
f
g recommended. In meidcal patients with risk factors for
____5/325______7.5/325_____10/325 tablet orally VTE in whom there is a contraindication to anticoagulant
every _____4hr._____6hr. as needed for pain prophylaxis, GCS or IPC is recommended.
c oxycodone _____mg tablet orally every
d
e
f
g c Early and persistant mobilization
d
e
f
g
_____4hr._____6hr. as needed for pain
c Graded compression stockings (1530 mm Hg of
d
e
f
g
pressure at the ankle)
Order Initiated By: _________________________ Date/Time: _______________
Physician Signature: ________________________ Date/Time: _______________
Released: April 2, 2009
Telephone/Verbal Orders: gc Read Back g
d
e
f c Confirmed
d
e
f Page &p of &P
patient imprint
PHYSICIAN'S ORDER SHEET
Another brand of a generically equivalent product identical in dosage
form and content of active ingredient may be administered unless
indicated.
c Sequential Compression Device
d
e
f
g
c CBC every other day starting on day 4 of heparin
d
e
f
g Other:______________________
therapy thru day 14 or until Unfractionated
c MRA neck ___with __without contrast. Evidence
d
e
f
g
heparin/LMWH is discontinued.
c MRA brain __with contrast __without contrast Evidence
d
e
f
g
LowDose Unfractionated Heparin c MRI, brain, without contrast Evidence
d
e
f
g
c heparin 5,000 unit subcutaneously every 8 hours
d
e
f
g c MRI, brain, with contrast Evidence
d
e
f
g
LowMolecularWeight Heparins c Ultrasound, carotid, Doppler, bilateral Evidence
d
e
f
g
c enoxaparin /LOVENOX 40 milligram subcutaneously g
d
e
f
g c Interventional radiology, angiogram, aortic arch study
d
e
f
once a day with intracranial vessels
Stress Ulcer Prophylaxis c Interventional radiology, angiogram, carotid, cerebral,
d
e
f
g
c Initiate Stress Ulcer Prophylaxis Protocol
d
e
f
g bilateral Evidence
Laboratory c Interventional radiology, angiogram, carotid, cerebral,
d
e
f
g
b Complete blood cell count with automated white blood
c
d
e
f
g left Evidence
cell differential Evidence c Interventional radiology, angiogram, carotid, cerebral,
d
e
f
g
b Erythrocyte sedimentation rate (ESR)
c
d
e
f
g right Evidence
b Partial thromboplastin time (PTT), activated
c
d
e
f
g
c Interventional radiology, angiogram, carotid, cervical,
d
e
f
g
b Prothrombin time (PT) and international normalized ratio
c
d
e
f
g
(INR) Evidence bilateral Evidence
c Basic metabolic panel
d
e
f
g c
d
e
f
g Interventional radiology, angiogram, carotid, cervical,
c Comprehensive metabolic panel
d
e
f
g left Evidence
b Lipid panel
c
d
e
f
g c Interventional radiology, angiogram, carotid, cervical,
d
e
f
g
c Magnesium (Mg) Evidence
d
e
f
g right Evidence
c Phosphorus level Evidence
d
e
f
g c Interventional radiology, angiogram, intracranial
d
e
f
g
c Creatine kinase, total (CKtotal) , CKMB isoenzyme,
d
e
f
g Evidence
troponin Consults
c Rapid plasma reagin (RPR), qualitative
d
e
f
g c Consult to cardiology Evidence
d
e
f
g
b Urinalysis (UA) with microscopy
c
d
e
f
g c Consult to dietitian, adult Evidence
d
e
f
g
c Toxicology drug screen, urine
d
e
f
g c Consult to internal medicine
d
e
f
g
c Hypercoagulopathy panel (protein C deficiency, protein S
d
e
f
g
deficiency, lupus anticoagulant, anticardolipin antibodies, gc Consult to Acute inpatient rehabilitation Evidence
d
e
f
activated protein C resistance, factor V Leiden, c Consult to neurology
d
e
f
g
Prothrombin gene analysis) c Consult to occupational therapy
d
e
f
g
Avoid the routine ordering of tests to identify coagulation c Consult to Palliative Care
d
e
f
g
defects (eg, protein C deficiency, protein S deficiency, c Consult to physical therapy
d
e
f
g
lupus anticoagulant, anticardiolipin antibodies, activated c Consult to speech therapy
d
e
f
g
protein C resistance/factor V Leiden mutation) Evidence c Consult to vascular surgery Evidence
d
e
f
g
Diagnostic Tests
b 12lead ECG Evidence
c
d
e
f
g
c Echocardiogram, transthoracic Evidence
d
e
f
g
c Echocardiogram, transesophageal Evidence
d
e
f
g
c Radiograph, chest, 1 view Evidence
d
e
f
g
c Radiograph, chest, 2 views Evidence
d
e
f
g
c Radiograph, swallowing function, with cineradiography
d
e
f
g
and/or videoradiography (modified barium swallow)
Evidence
c CT, head or brain, without contrast on admission
d
e
f
g
Evidence
c CT Angiography of the head Evidence
d
e
f
g
c CT Angiography of the neck. Evidence
d
e
f
g
Order Initiated By: _________________________ Date/Time: _______________
Physician Signature: ________________________ Date/Time: _______________
Released: April 2, 2009
Telephone/Verbal Orders: gc Read Back g
d
e
f c Confirmed
d
e
f Page &p of &P
Print Only Selected Items Print All